Shanghai Henlius Biotech (OTCPK:SGBCF) is in talks with pharmaceutical giants such as Johnson & Johnson (JNJ) and Roche Holding AG (OTCQX:RHHBY) about selling them the rights to an experimental cancer drug, Bloomberg News reported early on Tuesday.
The agreement could
Source link
